SCHEMBL22378595

SCHEMBL22378595

N#Cc1cc(-c2ccccc2-n2c3ccccc3c3ccccc32)ccc1-c1ccc(-n2c3ccccc3c3ccccc32)cc1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NR3C1 P04150 1/20 0.38
ESR2 Q92731 1/20 0.38
TRPA1 O75762 1/20 0.36
ALOX5AP P20292 1/20 0.34
FEN1 P39748 1/20 0.34
PPARG P37231 1/20 0.34
IMPDH2 P12268 1/20 0.34
ALDH1A1 P00352 3/20 0.33
AR P10275 1/20 0.33
XDH P47989 1/20 0.33
CYP1A2 P05177 2/20 0.33
CYP3A4 P08684 2/20 0.33
HSD17B10 Q99714 2/20 0.33
CYP19A1 P11511 1/20 0.33
MAPK1 P28482 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33
HPGD P15428 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22378591 0.93 ALDH1A1 (0.39) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22377514 0.92 NR3C1 (0.37) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22377720 0.92 ALDH1A1 (0.38) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22377719 0.92 TRPA1 (0.37) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22379037 0.92 STS (0.38) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22377509 0.92 NR3C1 (0.38) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22377547 0.92 NR3C1 (0.36) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22379386 0.92 STS (0.38) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL19755390 0.91 KDM4E (0.44) KDM4EATML3MBTL1NR3C1ESR2
SCHEMBL22377533 0.91 KDM4E (0.39) KDM4EATML3MBTL1NR3C1ESR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same SAMSUNG ELECTRONICS CO., LTD. (KR) 2023-10-24 US disclosed
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG ELECTRONICS CO., LTD. (KR) 2020-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200274074-A1 HETEROCYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885
US-11800797-B2 Heterocyclic compound and organic light-emitting device including the same CRY1, CYP1A1, CRY2 KDM4E 3290/4885ATM 3429/4885L3MBTL1 1164/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.